Image Place holder

Julian Sanchez, MD

 
Specialty: Surgery
Program: Gastrointestinal Oncology

Overview

Cancer Focus: Anal Cancer, Appendiceal (Appendix) Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer, Small Intestine Cancer

Dr. Julian Sanchez is a colorectal surgeon in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. He is Associate Professor of Surgery and Associate Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. He is board certified in both general surgery and in colorectal surgery. Dr. Sanchez’s clinical interests include colon and rectal cancer, anal cancer, high resolution anoscopy, genetic cancer syndromes, and minimally invasive surgery. His research centers on HPV infection and associated anal cancer. He is especially interested in the progression of anal dysplasia in immunosuppression and in screening programs for high risk patients. Dr. Sanchez is originally from South Florida and graduated with highest honors from the University of Florida with a degree in Biochemistry. He attended Tufts University School of Medicine and graduated in 2003. Dr. Sanchez came to the University of South Florida for his general surgery residency and spent additional time researching colorectal cancer genetics. After completing general surgery residency, Dr. Sanchez received additional, specialized training in colon and rectal surgery at the Cleveland Clinic in Ohio. He practiced as a colorectal cancer surgeon in Los Angeles before returning to Moffitt Cancer Center in 2013. His research has been published in multiple journal articles, and he has written several book chapters. He is a member of the American College of Surgeons, the American Society of Colon and Rectal Surgeons, the Society of Surgical Oncology, and the International Anal Neoplasia Society. Dr. Sanchez is fluent in Spanish.


Education & Training

Board Certification:

  • Colon & Rectal Surgery
  • Surgery

Fellowship:

  • Cleveland Clinic, Ohio - Colorectal Surgery

Residency:

  • University of South Florida - General Surgery

Medical School:

  • Tufts University School of Medicine - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Naffouje S, Sabesan A, Powers BD, Dessureault S, Sanchez J, Schell M, Imanirad I, Sahin I, Xie H, Felder S. Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision. Clin Colorectal Cancer. 2021 Sep.20(3):e155-e164. Pubmedid: 33775560.
  • Felder SI, Feuerlein S, Parsee A, Imanirad I, Sanchez J, Dessureault S, Kim R, Hoffe S, Frakes J, Costello J. Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples. Abdom Radiol (NY). 2021 May.46(5):1783-1804. Pubmedid: 33111189.
  • Dohm A, Sanchez J, Stotsky-Himelfarb E, Willingham FF, Hoffe S. Strategies to Minimize Late Effects From Pelvic Radiotherapy. Am Soc Clin Oncol Educ Book. 2021 Mar.41:158-168. Pubmedid: 34010045.
  • Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel). 2021 Jul.13(15). Pubmedid: 34359718. Pmcid: PMC8345133.
  • Shindorf ML, Copeland AR, Gupta S, Steinberg SM, Steele SR, Yeo HL, Sanchez JA, Hernandez JM. Evaluation of Factors Associated With Successful Matriculation to Colon and Rectal Surgery Fellowship. Dis Colon Rectum. 2021 Feb.64(2):234-240. Pubmedid: 33315718.
  • Yuan Z, Frazer M, Rishi A, Latifi K, Tomaszewski MR, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Zhang GG, Frakes JM. Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy. Rep Pract Oncol Radiother. 2021 Feb.26(1):29-34. Pubmedid: 33948299. Pmcid: PMC8086711.
  • Dhahri A, Kaplan J, Naqvi SMH, Brownstein NC, Ntiri SO, Imanirad I, Felder SI, Dineen SP, Sanchez J, Dessureault S, Carballido E, Powers BD. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset. Cancer Med. 2021 Aug.10(16):5643-5652. Pubmedid: 34197047. Pmcid: PMC8366079.
  • Sutter ME, Simmons VN, Sutton SK, Vadaparampil ST, Sanchez JA, Bowman-Curci M, Duarte L, Schabath MB, Quinn GP. Oncologists' experiences caring for LGBTQ patients with cancer: Qualitative analysis of items on a national survey. Patient Educ Couns. 2021 Apr.104(4):871-876. Pubmedid: 32981814. Pmcid: PMC7982350.
  • Yuan Z, Frazer M, Ahmed KA, Naqvi SMH, Schell MJ, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Torres-Roca JF, Hoffe SE, Frakes JM. Modeling precision genomic-based radiation dose response in rectal cancer. Future Oncol. 2020 Oct.16(30):2411-2420. Pubmedid: 32686956.
  • Frazer ML, Yang G, Felder S, McDonald J, Sanchez J, Dessureault S, Imanirad I, Carballido E, Kim RD, Hoffe SE, Frakes JM. Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation. Am J Clin Oncol. 2020 May.43(5):319-324. Pubmedid: 32028341.
  • Yuan Z, Frazer M, Zhang GG, Latifi K, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Frakes JM. CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study. J Med Imaging Radiat Oncol. 2020 Jun.64(3):444-449. Pubmedid: 32386109.
  • Berry-Lawhorn JM, Sanchez JA. Now Is the Time to Work Together!. Dis Colon Rectum. 2019 Sep.62(9):e413. Pubmedid: 31397755.
  • Schabath MB, Blackburn CA, Sutter ME, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. J Clin Oncol. 2019 Mar.37(7):547-558. Pubmedid: 30650044. Pmcid: PMC6553841.
  • Gwede CK, Sutton SK, Chavarria EA, Gutierrez L, Abdulla R, Christy SM, Lopez D, Sanchez J, Meade CD. A culturally and linguistically salient pilot intervention to promote colorectal cancer screening among Latinos receiving care in a Federally Qualified Health Center. Health Educ Res. 2019 Jun.34(3):310-320. Pubmedid: 30929015. Pmcid: PMC7868960.
  • Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA, Freedman-Cass DA. AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2019 Feb.17(2):171-189. Pubmedid: 30787130.
  • Wheldon CW, Schabath MB, Hudson J, Bowman Curci M, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP. Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health. 2018 Apr.5(3):203-211. Pubmedid: 29641317. Pmcid: PMC5905865.
  • Tamargo CL, Quinn GP, Sanchez JA, Schabath MB. Cancer and the LGBTQ Population: Quantitative and Qualitative Results from an Oncology Providers' Survey on Knowledge, Attitudes, and Practice Behaviors. J Clin Med. 2017 Oct.6(10). Pubmedid: 28991160. Pmcid: PMC5664008.
  • Hudson J, Schabath MB, Sanchez J, Sutton S, Simmons VN, Vadaparampil ST, Kanetsky PA, Quinn GP. Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Survey. J Natl Compr Canc Ne. 2017 Nov.15(11):1379-1382. Pubmedid: 29118229. Pmcid: PMC5705047.
  • Schabath MB, Curci MB, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Wheldon C, Quinn GP. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017 Aug.13(8):542-546. Pubmedid: 28719237.
  • Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016 Oct.99(10):1676-1684. Pubmedid: 27161166. Pmcid: PMC5527558.
  • Hanna C, Mullinax J, Friedman MS, Sanchez J. Jejunal diverticulosis found in a patient with long-standing pneumoperitoneum and pseudo-obstruction on imaging: a case report. Gastroenterol Rep (Oxf). 2016 Nov.4(4):337-340. Pubmedid: 26220890. Pmcid: PMC5193057.
  • Seydafkan S, Shibata D, Sanchez J, Tran ND, Leon M, Coppola D. Pathology Report: Presacral Noncommunicating Enteric Duplication Cyst. Cancer Control. 2016 Apr.23(2):170-174. Pubmedid: 27218796.
  • Chen YJ, Chen MB, Liu AJ, Sanchez J, Tsai P, Liu A. Dosimetric coverage of the external anal sphincter by 3-dimensional conformal fields in rectal cancer patients receiving neoadjuvant chemoradiation: implications for the concept of sphincter-preserving radiation therapy. Biomed Res Int. 2015 Sep.2014:578243. Pubmedid: 25089274. Pmcid: PMC4095991.
  • Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, Kanetsky PA, Schabath MB. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA-Cancer J Clin. 2015 Dec.65(5):384-400. Pubmedid: 26186412. Pmcid: PMC4609168.
  • Quinn GP, Schabath MB, Sanchez JA, Sutton SK, Green BL. The importance of disclosure: lesbian, gay, bisexual, transgender/transsexual, queer/questioning, and intersex individuals and the cancer continuum. Cancer. 2015 Apr.121(8):1160-1163. Pubmedid: 25521303. Pmcid: PMC4505934.
  • Patel SS, Nelson R, Sanchez J, Lee W, Uyeno L, Garcia-Aguilar J, Hurria A, Kim J. Elderly patients with colon cancer have unique tumor characteristics and poor survival. Cancer. 2013 Feb.119(4):739-747. Pubmedid: 23011893.
  • Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. Int J Mol Sci. 2012 Sep.13(10):12153-12168. Pubmedid: 23202889 . Pmcid: PMC3497263.
  • Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci. 2012 Sep.13(10):12153-12168. Pubmedid: 23202889. Pmcid: PMC3497263.
  • Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum. 2012 Feb.55(2):128-133. Pubmedid: 22228154.
  • Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep.17(9):1966-1970. Pubmedid: 21618350.
  • Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep.17(9):1966-1970. Pubmedid: 21618350.
  • Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May.147(5):713-719. Pubmedid: 20004437.
  • Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May.147(5):713-719. Pubmedid: 20004437.
  • Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Kalady MF, DeJulius KL, Manilich E, Church JM, Casey G, Skacel M. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg. 2009 Oct.96(10):1196-1204. Pubmedid: 19787768.
  • Kalady MF, Sanchez JA, Manilich E, Hammel J, Casey G, Church JM. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Dis Colon Rectum. 2009 Jun.52(6):1039-1045. Pubmedid: 19581844.
  • Messick CA, Sanchez J, Dejulius KL, Church JM, Kalady MF. Genetic and molecular diversity of colon cancer hepatic metastases. Surgery. 2009 Aug.46(2):227-231. Pubmedid: 19628078.
  • Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene. 2008 Oct.27(46):6044-6055. Pubmedid: 18591935. Pmcid: PMC2574581.
  • Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec.51(12):1750-1756. Pubmedid: 18682882.
  • Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec.51(12):1750-1756. Pubmedid: 18682882.
  • Christy SM, Cousin LA, Sutton SK, Chavarria EA, Abdulla R, Gutierrez L, Sanchez J, Lopez D, Gwede CK, Meade CD. Characterizing Health Literacy Among Spanish Language-Preferring Latinos Ages 50-75. Nurs Res. 70(5):344-353. Pubmedid: 33990120. Pmcid: PMC8405461.

Grants

Title: Health Equity Leadership Program (HELP): An Equity of Care Catalyst Development Program
Sponsor: Florida Blue Fdtn
PI: Villarroel de Chachula, D., CO-PI: Green, L., CO-PI: Sanchez, J.

Patient Comments
Overall Satisfaction
0

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments